Methods to avoid infections in patients with inflammatory bowel disease

Inflamm Bowel Dis. 2005 Jul;11(7):685-95. doi: 10.1097/01.mib.0000160742.91602.b7.

Abstract

Infections have been reported in patients with inflammatory bowel disease (IBD), especially in association with anti-inflammatory and immunomodulatory medications used to treat IBD. Unfortunately, there is a dearth of information on infectious complication risk in patients with IBD. This review describes infectious complications reported in patients with IBD and provides a framework for future studies to assess potential risk factors and incidence for infection. Recommendations are also provided for prevention of infection.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / adverse effects
  • Causality
  • Communicable Disease Control*
  • Humans
  • Immunologic Factors / adverse effects
  • Immunosuppressive Agents / adverse effects
  • Infections / etiology*
  • Inflammatory Bowel Diseases / complications*
  • Inflammatory Bowel Diseases / drug therapy
  • Opportunistic Infections / etiology
  • Opportunistic Infections / prevention & control*

Substances

  • Anti-Inflammatory Agents
  • Immunologic Factors
  • Immunosuppressive Agents